Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (61 ops.)
Latest filing published 24 Jan 2023 for Pear Therapeutics, Inc., €20k.
Filing timeline
BuySaleChristopherd T. Guiffre
Insider track record
Disclosed buys
0
Disclosed sells
61
Signal history
Christopherd T. Guiffre: trading record in brief
Christopherd T. Guiffre is a declared insider at 3 companies; the most frequent names are Cubist Pharmaceuticals Inc, Cerulean Pharma Inc. and Pear Therapeutics, Inc. Between 3 January 2006 and 20 January 2023, the trades on record add up to 83 filings.
No open-market purchase appears, only 61 sales worth €863k. The rest of the record consists of 3 share grants and 6 option exercises. 2023 to date brings no purchases and 1 sale.
On 24 January 2023 came the latest disclosure, an open-market sale for €20k in Pear Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christopherd T. Guiffre
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations82 total
19,540 shares@ US$1.13100.0% of flowClass A Common StockSEC:0001062993-23-001325:0
49,500 shares0Common StockSEC:0001062993-23-001038:0
5,733 shares@ US$0.6033.4% of flowCommon StockSEC:0001209191-17-002068:0
3,999 shares@ US$1.8066.6% of flowCommon StockSEC:0001209191-16-132163:0
2,757 sharesCommon StockSEC:0001209191-16-090357:0
307 shares@ US$18.42Common StockSEC:0001219021-08-000003:0
253 shares@ US$17.14Common StockSEC:0001219021-08-000001:0
49 shares@ US$21.13Common StockSEC:0001219021-07-000009:0
20,000 shares@ US$10.84Common StockSEC:0001219021-07-000007:0
250 shares@ US$22.68Common StockSEC:0001219021-07-000007:1
1,497 shares@ US$22.69Common StockSEC:0001219021-07-000007:2
800 shares@ US$22.70Common StockSEC:0001219021-07-000007:3
200 shares@ US$22.71Common StockSEC:0001219021-07-000007:4
300 shares@ US$22.73Common StockSEC:0001219021-07-000007:5
100 shares@ US$22.74Common StockSEC:0001219021-07-000007:6
1,800 shares@ US$22.75Common StockSEC:0001219021-07-000007:7
226 shares@ US$22.75Common StockSEC:0001219021-07-000007:8
380 shares@ US$22.76Common StockSEC:0001219021-07-000007:9
220 shares@ US$22.80Common StockSEC:0001219021-07-000007:10
9 shares@ US$22.86Common StockSEC:0001219021-07-000007:11
1,100 shares@ US$22.87Common StockSEC:0001219021-07-000007:12
2,090 shares@ US$22.88Common StockSEC:0001219021-07-000007:13
200 shares@ US$22.90Common StockSEC:0001219021-07-000007:14
3,200 shares@ US$22.91Common StockSEC:0001219021-07-000007:15
1,600 shares@ US$22.92Common StockSEC:0001219021-07-000007:16
25 of 82 declarations
